Allison DB - Search Results

1

Risk of Type 2 Diabetes Among Individuals with Excess Weight: Weight Trajectory Effects.

Owora AH, Allison DB, Zhang X, Gletsu-Miller N, Gadde KM. Owora AH, et al. Among authors: allison db. Curr Diab Rep. 2022 Sep;22(9):471-479. doi: 10.1007/s11892-022-01486-9. Epub 2022 Jul 4. Curr Diab Rep. 2022. PMID: 35781782 Free PMC article. Review.

2

Bupropion SR vs. placebo for weight loss in obese patients with depressive symptoms.

Jain AK, Kaplan RA, Gadde KM, Wadden TA, Allison DB, Brewer ER, Leadbetter RA, Richard N, Haight B, Jamerson BD, Buaron KS, Metz A. Jain AK, et al. Among authors: allison db. Obes Res. 2002 Oct;10(10):1049-56. doi: 10.1038/oby.2002.142. Obes Res. 2002. PMID: 12376586 Free article. Clinical Trial.

3

Atomoxetine for weight reduction in obese women: a preliminary randomised controlled trial.

Gadde KM, Yonish GM, Wagner HR 2nd, Foust MS, Allison DB. Gadde KM, et al. Among authors: allison db. Int J Obes (Lond). 2006 Jul;30(7):1138-42. doi: 10.1038/sj.ijo.0803223. Epub 2006 Jan 17. Int J Obes (Lond). 2006. PMID: 16418753 Clinical Trial.

4

Cannabinoid-1 receptor antagonist, rimonabant, for management of obesity and related risks.

Gadde KM, Allison DB. Gadde KM, et al. Among authors: allison db. Circulation. 2006 Aug 29;114(9):974-84. doi: 10.1161/CIRCULATIONAHA.105.596130. Circulation. 2006. PMID: 16940206 No abstract available.

5

Combination pharmaceutical therapies for obesity.

Gadde KM, Allison DB. Gadde KM, et al. Among authors: allison db. Expert Opin Pharmacother. 2009 Apr;10(6):921-5. doi: 10.1517/14656560902824152. Expert Opin Pharmacother. 2009. PMID: 19351275 Free PMC article.

6

Combination therapy for obesity and metabolic disease.

Gadde KM, Allison DB. Gadde KM, et al. Among authors: allison db. Curr Opin Endocrinol Diabetes Obes. 2009 Oct;16(5):353-8. doi: 10.1097/MED.0b013e3283304f90. Curr Opin Endocrinol Diabetes Obes. 2009. PMID: 19625958 Review.

7

Sample size in obesity trials: patient perspective versus current practice.

Allison DB, Elobeid MA, Cope MB, Brock DW, Faith MS, Vander Veur S, Berkowitz R, Cutter G, McVie T, Gadde KM, Foster GD. Allison DB, et al. Med Decis Making. 2010 Jan-Feb;30(1):68-75. doi: 10.1177/0272989X09340583. Epub 2009 Aug 12. Med Decis Making. 2010. PMID: 19675318 Free PMC article.

8

Missing data in randomized clinical trials for weight loss: scope of the problem, state of the field, and performance of statistical methods.

Elobeid MA, Padilla MA, McVie T, Thomas O, Brock DW, Musser B, Lu K, Coffey CS, Desmond RA, St-Onge MP, Gadde KM, Heymsfield SB, Allison DB. Elobeid MA, et al. Among authors: allison db. PLoS One. 2009 Aug 13;4(8):e6624. doi: 10.1371/journal.pone.0006624. PLoS One. 2009. PMID: 19675667 Free PMC article.

9

Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial.

Gadde KM, Allison DB, Ryan DH, Peterson CA, Troupin B, Schwiers ML, Day WW. Gadde KM, et al. Among authors: allison db. Lancet. 2011 Apr 16;377(9774):1341-52. doi: 10.1016/S0140-6736(11)60205-5. Epub 2011 Apr 8. Lancet. 2011. PMID: 21481449 Clinical Trial.

10

Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP).

Allison DB, Gadde KM, Garvey WT, Peterson CA, Schwiers ML, Najarian T, Tam PY, Troupin B, Day WW. Allison DB, et al. Obesity (Silver Spring). 2012 Feb;20(2):330-42. doi: 10.1038/oby.2011.330. Epub 2011 Nov 3. Obesity (Silver Spring). 2012. PMID: 22051941 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

871 results

Search Page

Filters